Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.70
-0.57 (-2.26%)
At close: Mar 26, 2026, 4:00 PM EDT
24.70
0.00 (0.00%)
After-hours: Mar 26, 2026, 5:30 PM EDT
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $734.36 million as of March 26, 2026. Its market cap has increased by 31.20% in one year.
Market Cap
734.36M
Enterprise Value
471.87M
1-Year Change
31.20%
Ranking
Category
Stock Price
$24.70
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $734.36M, an increase of 496.79%. That is a compound annual growth rate of 30.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 734.36M | -35.32% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.61B |
| GRAIL | 2.14B |
| GeneDx Holdings | 1.96B |
| NeoGenomics | 1.01B |
| CareDx | 925.99M |
| OPKO Health | 913.56M |
| Personalis | 805.67M |
| Burning Rock Biotech | 540.25M |